Bertha K. Madras
Department of Psychiatry
Harvard Medical School
Southborough
Massachusetts 01772-9102
USA
Name/email consistency: high
- Office of National Drug Control Policy: a scientist in drug policy in Washington, DC. Madras, B.K. Ann. N. Y. Acad. Sci. (2010)
- Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Madras, B.K., Compton, W.M., Avula, D., Stegbauer, T., Stein, J.B., Clark, H.W. Drug. Alcohol. Depend (2009)
- Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. Madras, B.K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Livni, E., Spencer, T.J., Bonab, A.A., Miller, G.M., Fischman, A.J. J. Pharmacol. Exp. Ther. (2006)
- Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo. Madras, B.K., Fahey, M.A., Goulet, M., Lin, Z., Bendor, J., Goodrich, C., Meltzer, P.C., Elmaleh, D.R., Livni, E., Bonab, A.A., Fischman, A.J. J. Pharmacol. Exp. Ther. (2006)
- The dopamine transporter and attention-deficit/hyperactivity disorder. Madras, B.K., Miller, G.M., Fischman, A.J. Biol. Psychiatry (2005)
- Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Madras, B.K., Fahey, M.A., Miller, G.M., De La Garza, R., Goulet, M., Spealman, R.D., Meltzer, P.C., George, S.R., O'Dowd, B.F., Bonab, A.A., Livni, E., Fischman, A.J. Eur. J. Pharmacol. (2003)
- The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Madras, B.K., Miller, G.M., Fischman, A.J. Behav. Brain Res. (2002)









